Transplantation for CML: 2010

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations


In this issue of Blood, Saussele and colleagues from the German CML study group present data obtained from an interim safety analysis of a prospective multiarm trial in which allogeneic stem cell transplantation was used up front in selected low-risk CMLpatients, up front in patients presenting with advanced disease, or as planned second-line therapy after imatinib failure.

Original languageEnglish (US)
Pages (from-to)1860-1861
Number of pages2
Issue number10
StatePublished - Mar 11 2010

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Transplantation for CML: 2010'. Together they form a unique fingerprint.

Cite this